{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:14:19Z","timestamp":1648743259064},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00115-011-3269-8","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T04:49:59Z","timestamp":1302583799000},"page":"511-521","source":"Crossref","is-referenced-by-count":2,"title":["Muskul\u00e4re Kanalopathien"],"prefix":"10.1007","volume":"82","author":[{"given":"K.","family":"Jurkat-Rott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lehmann-Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,13]]},"reference":[{"key":"3269_CR1","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1334::AID-MUS16>3.0.CO;2-1","volume":"21","author":"Deymeer","year":"1998","unstructured":"Deymeer F, Cakirkaya S, Serdaroglu P et al (1998) Transient weakness and compound muscle action potential decrement in myotonia congenita. Muscle Nerve 21:1334\u20131337","journal-title":"Muscle Nerve"},{"key":"3269_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.nmd.2008.01.007","volume":"19","author":"Dupr\u00e9","year":"2009","unstructured":"Dupr\u00e9 N, Chrestian N, Bouchard JP et al (2009) Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians. Neuromuscul Disord 19:330\u2013334","journal-title":"Neuromuscul Disord"},{"key":"3269_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nurt.2007.01.012","volume":"4","author":"Heatwole","year":"2007","unstructured":"Heatwole CR, Moxley RT 3rd (2007) The nondystrophic myotonias. Neurotherapeutics 4:238\u2013251","journal-title":"Neurotherapeutics"},{"key":"3269_CR4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2169\/internalmedicine.41.743","volume":"41","author":"Ikeda","year":"2002","unstructured":"Ikeda K, Iwasaki Y, Kinoshita M et al (2002) Acetazolamide-induced weakness in hypokalemic periodic paralysis. Intern Med 41:743\u2013745","journal-title":"Intern Med"},{"key":"3269_CR5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.59.3.466","volume":"59","author":"Junker","year":"2002","unstructured":"Junker J, Haverkamp W, Schulze-Bahr E et al (2002) Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology 59:466","journal-title":"Neurology"},{"key":"3269_CR6","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI25525","volume":"115","author":"Jurkat-Rott","year":"2005","unstructured":"Jurkat-Rott K, Lehmann-Horn F (2005) Muscle channelopathies and critical points in functional and genetic studies. J Clin Invest 115:2000\u20132009","journal-title":"J Clin Invest"},{"key":"3269_CR7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nurt.2007.02.001","volume":"4","author":"Jurkat-Rott","year":"2007","unstructured":"Jurkat-Rott K, Lehmann-Horn F (2007) Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics 4:216\u2013224","journal-title":"Neurotherapeutics"},{"key":"3269_CR8","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1073\/pnas.0811277106","volume":"106","author":"Jurkat-Rott","year":"2009","unstructured":"Jurkat-Rott K, Weber MA, Fauler M et al (2009) K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci U S A 106:4036\u20134041","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3269_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","volume":"15","author":"Klingler","year":"2005","unstructured":"Klingler W, Lehmann-Horn F, Jurkat-Rott K (2005) Complications of anesthesia in neuromuscular disorders. Neuromuscul Disord 15:195\u2013206","journal-title":"Neuromuscul Disord"},{"key":"3269_CR10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/mus.21155","volume":"39","author":"Kubota","year":"2009","unstructured":"Kubota T, Kinoshita M, Sasaki R et al (2009) New mutation of the Na channel in the severe form of potassium-aggravated myotonia. Muscle Nerve 39:666\u2013673","journal-title":"Muscle Nerve"},{"key":"3269_CR11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1152\/physrev.1999.79.4.1317","volume":"79","author":"Lehmann-Horn","year":"1999","unstructured":"Lehmann-Horn F, Jurkat-Rott K (1999) Voltage-gated ion channels and hereditary disease. Physiol Rev 79:1317\u20131372","journal-title":"Physiol Rev"},{"key":"3269_CR12","unstructured":"Lehmann-Horn F, R\u00fcdel R, Jurkat-Rott K (2004) Chapter 46: nondystrophic myotonias and periodic paralyses. In: Engel AG, Franzini-Armstrong C (Hrsg) Myology, 3. Aufl. McGraw-Hill, New York, S 1257\u20131300"},{"key":"3269_CR13","doi-asserted-by":"crossref","unstructured":"Lerche H, Heine R, Pika U et al (2003) Human sodium channel myotonia: nlowed channel inactivation due to substitutions for a glycine within the III\/IV linker. J Physiol (Lond) 470:13\u201322","DOI":"10.1113\/jphysiol.1993.sp019843"},{"key":"3269_CR14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/mus.20825","volume":"37","author":"Meyer","year":"2008","unstructured":"Meyer T, Jurkat-Rott K, Huebner A et al (2008) Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation. Muscle Nerve 37:120\u2013124","journal-title":"Muscle Nerve"},{"key":"3269_CR15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archneur.1994.00540230033009","volume":"51","author":"Ricker","year":"1994","unstructured":"Ricker K, Moxley RT, Heine R, Lehmann-Horn F (1994) Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol 51:1095\u20131102","journal-title":"Arch Neurol"},{"key":"3269_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","volume":"140","author":"Ryan","year":"2010","unstructured":"Ryan DP, Silva MR da, Soong TW et al (2010) Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 140:88\u201398","journal-title":"Cell"},{"key":"3269_CR17","first-page":"CD005045","volume":"23","author":"Sansone","year":"2008","unstructured":"Sansone V, Meola G, Links TP et al (2008) Treatment for periodic paralysis. Cochrane Database Syst Rev 23:CD005045","journal-title":"Cochrane Database Syst Rev"},{"key":"3269_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10048-009-0225-x","volume":"11","author":"Stunnenberg","year":"2010","unstructured":"Stunnenberg BC, Ginjaar HB, Trip J et al (2010) Isolated eyelid closure myotonia in two families with sodium channel myotonia. Neurogenetics 11:257\u2013260","journal-title":"Neurogenetics"},{"key":"3269_CR19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","volume":"47","author":"Tawil","year":"2000","unstructured":"Tawil R, McDermott MP, Brown R et al (2000) Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann Neurol 47:46\u201353","journal-title":"Ann Neurol"},{"key":"3269_CR20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1212\/01.wnl.0000233841.75824.0f","volume":"67","author":"Weber","year":"2006","unstructured":"Weber MA, Nielles-Vallespin S, Essig M et al (2006) Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology 67:1151\u20131158","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-011-3269-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3269-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:15:27Z","timestamp":1560122127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-011-3269-8"}},"subtitle":["Myotonien und periodische Paralysen"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1007\/s00115-011-3269-8","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}